TANG CAPITAL MANAGEMENT LLC Q4 2016 Filing
Filed February 14, 2017
Portfolio Value
$187.5B
Holdings
7
Report Date
Q4 2016
Filing Type
13F-HR
All Holdings (7 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | HRTXHERON THERAPEUTICS INC | 6,197,198 | $81.2B | 43.29% | |
| 2 | —LA JOLLA PHARMACEUTICAL CO | 3,191,165 | $55.9B | 29.83% | |
| 3 | —IGNYTA INC | 3,972,800 | $21.1B | 11.23% | |
| 4 | OPK 3 02/01/33 AIOPKO HEALTH INC | 14,000,000 | $19.4B | 10.32% | |
| 5 | BMRNBIOMARIN PHARMACEUTICAL INC | 90,215 | $7.5B | 3.99% | |
| 6 | —CYCLACEL PHARMACEUTICALS INC | 359,900 | $1.9B | 1.02% | |
| 7 | —ATYR PHARMA INC | 279,425 | $601.0M | 0.32% |